title: Hepatitis B reactivation despite entecavir prophylaxis in a patient with chronic lymphocytic leukaemia receiving bendamustine.
authors: Angela
authors: A
authors: Rago
authors: Lorenzo
authors: L
authors: Ridola
authors: Miriam
authors: M
authors: Lichtner
authors: Sergio
authors: S
authors: Mecarocci
authors: Raffaella
authors: R
authors: Marocco
authors: Natalia
authors: N
authors: Cenfra
authors: Valeria
authors: V
authors: Belvisi
authors: Claudio M
authors: CM
authors: Mastroianni
authors: Giuseppe
authors: G
authors: Cimino
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage; D000998:Antiviral Agents / Q000008:administration & dosage*; D000069461:Bendamustine Hydrochloride; D018890:Chemoprevention / Q000379:methods*; D004279:DNA, Viral / Q000097:blood; D006147:Guanine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D006509:Hepatitis B / Q000517:prevention & control* / Q000821:virology; D006515:Hepatitis B virus / Q000302:isolation & purification*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications* / Q000188:drug therapy; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D014775:Virus Activation
chemical_list: D000970:Antineoplastic Agents; D000998:Antiviral Agents; D004279:DNA, Viral; D009588:Nitrogen Mustard Compounds; C413685:entecavir; D006147:Guanine; D000069461:Bendamustine Hydrochloride